Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-12-18

FDA Approved: HEMANGEOL — Supplemental Application (Eton Pharmaceuticals, Inc.)

View source ↗

Summary

FDA entry documents a supplemental application for Hemangeol (propranolol hydrochloride) by Eton Pharmaceuticals. The submission status is AP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEMANGEOL (Propranolol hydrochloride)

Snippet

SUPPL AP for HEMANGEOL (PROPRANOLOL HYDROCHLORIDE)